Walleye Capital LLC Madrigal Pharmaceuticals, Inc. Put Options Transaction History

Walleye Capital LLC

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 14, 2024	BUY	$193.33 - $291.99 $38,666 - $58,398	200 Added 100.0%	400 $112,000
Q1 2024 May 15, 2024	BUY	$171.37 - $283.23 $34,274 - $56,646	200 New	200 $53,000
Q1 2023 May 15, 2023	BUY	$231.06 - $307.08 $231,060 - $307,080	1,000 New	1,000 $242,000
Q1 2020 May 15, 2020	SELL	$66.76 - $93.49 $60,084 - $84,141	-900 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$84.28 - $118.5 $379,260 - $533,250	-4,500 Reduced 83.33%	900 $82,000
Q1 2019 May 15, 2019	BUY	$103.48 - $143.84 $558,792 - $776,736	5,400 New	5,400 $676,000

335

22.3M

960K

940K

Ticker MDGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,103,400
Market Cap $5.81B
Description
Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.